glp-1 suicide Reassuring' findings suggest receptor agonists do not increase risk GLP-1 drugs and suicidal ideation:
Description
BMI is calculated from a respondents self-reported height and weight
121 WhiteA
The Phase 1 trial plans to enroll 32 healthy participants, divided into 4 cohorts, with each cohort consisting of 8 participants receiving IBI3032 or placebo in a 6:2
Addressing Constipation with Nutrients Constipation can be incredibly uncomfortable for users of GLP-1 medications
Jin Y, Dong H, Xia L, et al
